^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against ß-Catenin-activated Hepatocellular Carcinoma

Excerpt:
In HCC cell lines with a constitutively activated β-catenin, C-82 inhibited cell proliferation....Moreover, C-82 treatment significantly decreased the expression of cell proliferating markers and increased the expression of apoptosis-related proteins.
DOI:
10.21873/anticanres.14524